Financial Dilution

Mainz Biomed (MYNZ) has priced a $3.0 million follow-on offering at $1.35 per unit, consisting of 2,222,222 units. Each unit includes one ordinary share (or pre-funded warrant) and one Series A warrant exercisable at $1.35, expiring in five years. Maxim Group LLC is the sole placement agent. The offering is expected to close around August 5, 2025, subject to customary conditions. The offering provides minimal capital and potential shareholder dilution.